A detailed history of Primecap Management CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Primecap Management CO holds 76,000 shares of MRK stock, worth $9.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
76,000
Previous 84,500 10.06%
Holding current value
$9.41 Million
Previous $9.21 Million 8.86%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $962,540 - $1.12 Million
-8,500 Reduced 10.06%
76,000 $10 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $851,530 - $926,670
-8,500 Reduced 9.14%
84,500 $9.21 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $319,145 - $354,423
-3,100 Reduced 3.23%
93,000 $9.57 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $521,328 - $568,224
-4,800 Reduced 4.76%
96,100 $11.1 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $669,110 - $746,590
-6,500 Reduced 6.05%
100,900 $10.7 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $795,704 - $1.02 Million
-9,100 Reduced 7.81%
107,400 $11.9 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $1.56 Million - $1.75 Million
-18,400 Reduced 13.64%
116,500 $10 Million
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $559,383 - $634,088
-6,700 Reduced 4.73%
134,900 $12.3 Million
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $7.51 Million - $8.41 Million
-102,100 Reduced 41.9%
141,600 $11.6 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $19.4 Million - $24.3 Million
-268,700 Reduced 52.44%
243,700 $18.7 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $594,944 - $654,289
-8,300 Reduced 1.59%
512,400 $38.5 Million
Q2 2021

Aug 10, 2021

SELL
$70.31 - $77.77 $45.8 Million - $50.6 Million
-650,700 Reduced 55.55%
520,700 $40.5 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $90.2 Million - $106 Million
-1,310,400 Reduced 52.8%
1,171,400 $90.3 Million
Q4 2020

Feb 08, 2021

SELL
$71.77 - $79.65 $11.4 Million - $12.6 Million
-158,600 Reduced 6.01%
2,481,800 $203 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $12.6 Million - $14.3 Million
-172,100 Reduced 6.12%
2,640,400 $219 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $20.5 Million - $23.3 Million
-290,600 Reduced 9.36%
2,812,500 $217 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $19.1 Million - $26.4 Million
-301,000 Reduced 8.84%
3,103,100 $239 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $540,168 - $588,803
-7,100 Reduced 0.21%
3,404,100 $287 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $110 Million - $128 Million
-2,163,868 Reduced 38.81%
3,411,200 $186 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $7.68 Million - $9.17 Million
148,768 Added 2.74%
5,575,068 $314 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $318 Million - $343 Million
5,426,300
5,426,300 $347 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.